SEARCH

SEARCH BY CITATION

References

  • Amano T., Nakanishi H., Oka M. and Yamamoto K. (1995) Increased expression of cathepsins E and D in reactive microglial cells associated with spongiform degeneration in the brain stem of senescence-accelerated mouse. Exp. Neurol. 136, 171182.
  • Appleyard S. M., Bailey T. W., Doyle M. W., Jin Y. H., Smart J. L., Low M. J. and Andresen M. C. (2005) Proopiomelanocortin neurons in nucleus tractus solitarius are activated by visceral afferents: regulation by cholecystokinin and opioids. J. Neurosci. 25, 35783585.
  • Athauda S. B. P. and Takahashi K. (2002) Distinct cleavage specificity of human cathepsin E at neutral pH with special preference for Arg-Arg bonds. Protein Peptide Lett. 9, 1522.
  • Athauda S. B. P., Takahashi T., Inoue H., Ichinose M. and Takahashi K. (1991) Proteolytic activity and cleavage specificity of cathepsin E at the physiological pH as examined towards the B chain of oxidized insulin. FEBS Lett. 292, 5356.
  • Bannon M. J., Deutch A. Y., Tam S. Y., Zamir N., Eskay R. L., Lee J. M., Magio J. E. and Roth R. H. (1986) Mild footshock stress dissociates substance P from substance K and dynorphin from Met- and Leu-enkephalin. Brain Res. 381, 393396.
  • Bennett K., Levine T., Ellis J. S., Peanasky R. J., Samloff I. M., Kay J. and Chain B. M. (1992) Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22, 15191524.
  • Benuck M., Grynbaum A. and Marks N. (1977) Breakdown of somatostatin and substance P by cathepsin D purified from calf brain by affinity chromatography. Brain Res. 143, 181185.
  • Bilkei-Gorzo A. and Zimmer A. (2005) Mutagenesis and knockout models: NK-1 and substance P. Handb. Exp. Pharmacol. 169, 143162.
  • Block C. H., Hoffman G. and Kapp B. S. (1989) Peptide-containing pathways from the parabrachial complex to the central nucleus of the amygdala. Peptides 10, 465471.
  • Bourne A., Barnes K., Taylor B. A., Turner A. J. and Kenny A. J. (1989) Membrane peptidases in the pig choroid plexus and on other cell surfaces in contact with the cerebrospinal fluid. Biochem. J. 259, 6980.
  • Brodin E., Rosen A., Schott E. and Brodin K. (1994) Effects of sequential removal of rats from a group cage and of individual housing of rats, on substance P, cholecystokinin ans somatostatin levels in the periaqueductal grey and limbic regions. Neuropeptides 26, 253260.
  • Chain B. M., Free P., Medd P., Swetman C., Tabor A. B. and Terrazzini N. (2005) The expression and function of cathepsin E in dendritic cells. J. Immunol. 174, 17911800.
  • Cuello A. C. and Kanazawa I. (1978) The distribution of substance P immunoreactive fibers in the rat central nervous system. Peptides 7, 11091120.
  • Danzer M., Samberger C., Schicho R., Lippe I. T. and Holzer P. (2004) Immunocytochemical characterization of rat brainstem neurons with vagal afferent input from the stomach challenged by acid or ammonia. Eur. J. Neurosci. 19, 8592.
  • De Felipe C., Herrero J. F., O’Brien J. A., Palmer J. A., Doyle C. A., Smith A. J. H., Laird J. M. A., Belmonte C., Cervero F. and Hunt S. P. (1998) Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392, 394397.
  • Elliott P. J., Nemeroff C. B. and Kilts C. D. (1986) Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbens. Brain Res. 386, 379382.
  • Fukuda T. and Kosaka T. (2003) Ultrastructual study of gap junctions between dendrites of parvalbmin-containing GABAergic neurons in various neocortical areas of the adult rat. Neuroscience 120, 520.
  • Grady E. F., Garland A. M., Gamp P. D., Lovett M., Payan D. G. and Bunnett N. W. (1995) Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK-1 receptor. Mol. Biol. Cell 6, 509524.
  • Inagaki S., Sakanaka M., Shiosaka S., Senba E., Takatsuki K., Takagi H., Kawai Y., Minagawa H. and Tohyama M. (1982) Ontogeny of substance P-containing neuron system of the rat: Immunohistochemical analysis-I. Forebrain and upper brain stem. Neuroscience 7, 251277.
  • Kageyama T.(1993) Rabbit procathepsin E and cathepsin E. Nucleotide sequence of cDNA, hydrolytic specificity for biologically active peptides and gene expression during development. Eur. J. Biochem. 216, 717728.
  • Kageyama T., Ichinose M. and Yonezawa S. (1995) Processing of the precursors to neurotensin and other bioactive peptides by cathepsin E. J. Biol. Chem. 270, 1913519140.
  • Kawakubo T., Okamoto K., Iwata J., Shin M., Okamoto Y., Yasukochi A., Nakayama K. I., Kadowaki T., Tsukuba T. and Yamamoto K. (2007) Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface. Cancer Res. 67, 1086910878.
  • Kenny A. J., Booth A. G., George S. G., Ingram J., Kershaw D., Wood E. J. and Young A. R. (1976) Dipeptidyl peptidase IV, a kidney brush-border serine peptidase. Biochem. J. 157, 169182.
  • Lisoprawski A., Blanc G. and Glowinski J. (1981) Activation by stress of the habenulo-interpenduncular substance P neurons in the rat. Neurosci. Lett. 25, 4751.
  • Ljungdahl A., Hökfelt T. and Nilsson G. (1978) Distribution of substance P-like immunoreactivity in the central nervous system of the rat-I. Cell bodies and nerve terminals. Neuroscience 3, 861943.
  • Mantyh P. W., Hunt S. P. and Maggio J. E. (1984) Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand. Brain Res. 307, 147165.
  • Marchand J. E., Shimonaka H. and Kream R. M. (1991) Biochemical characterization and anatomical distribution of a major form of unamidated precursor of substance P in rat brain. Brain Res. 567, 290305.
  • Matsas R., Fulcher I. S., Kenny A. J. and Turner A. J. (1983) Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc. Natl Acad. Sci. USA 80, 31113115.
  • McLean S., Ganong A. H., Seeger F. T., Bryce D. K., Pratt J. G., Reynolds L. S., Siok C. J., Lowwe J. A. and Heim J. (1991) Activity and distribution of different binding sites in brain of non-peptide substance P (NK-1) receptor antagonist. Science 251, 437439.
  • Michl T., Jocic M., Heinemann A., Schuligoi R. and Holzer P. (2001a) Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain. Pain 92, 1927.
  • Michl T., Jocic M., Heinemann A., Schuligoi R. and Holzer P. (2001b) Role of tachykinin receptors in the central processing of afferent input from the acid-threatened rat stomach. Regul. Pept. 102, 119126.
  • Nakanishi H., Tsukuba T., Kondou T., Tanaka T. and Yamamoto K. (1993) Transient forebrain ishchemia induces increased expression and specific localization of cathepsins E and D in rat hippocampus and neostriatum. Exp. Neurol. 121, 215223.
  • Nakanishi H., Tominaga K., Amano T., Hirotsu I., Inoue T. and Yamamoto K. (1994) Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues. Exp. Neurol. 126, 119128.
  • Nakanishi H., Amano T., Sastradipura D. F., Yoshimine Y., Tsukuba T., Tanabe K., Hirotsu I., Ohono T. and Yamamoto K. (1997) Increased expression of cathepsins E and D in neurons of the aged rat brain and their colocalization of Alzheimer amyloid precursor protein. J. Neurochem. 68, 739749.
  • Nakaya Y., Kaneko T., Shigemoto R., Nakanishi S. and Mizuno N. (1994) Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 347, 249274.
  • Nishioku T., Hashimoto K., Yamashita K. et al. (2002) Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia. J. Biol. Chem. 277, 48164822.
  • Nishishita K., Sakai H., Sakai E., Kato Y. and Yamamoto K. (1996) Age-related and dexamethasone-induced changes in cathepsins E and D in rat thymic and splenic cells. Arch. Biochem. Biophys. 333, 349358.
  • Okamoto A., Lovett M., Payan D. G. and Bunnett N. W. (1994) Interactions between neutral endopeptidase (EC 3.4.24.11) and the substance P (NK-1) receptor expressed in mammalian cells. Biochem. J. 299, 683693.
  • Persson S., Le Grevés P., Thörnvall M., Eriksson U., Silberring J. and Nyberg F. (1995) Neuropeptide converting and processing enzymes in the spinal cord and cerebrospinal fluid. Prog. Brain Res. 104, 111130.
  • Riche D., De Pommery J. and Menetrey D. (1990) Neuropeptides and catecholamines in efferent projections of the nuclei of the solitary tract in the rat. J. Comp. Neurol. 293, 399424.
  • Rosen A., Brodin K., Eneroth P. and Brodin E. (1992) Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain. Acta Physiol. Scand. 146, 341348.
  • Sakai H., Saku T., Kato Y. and Yamamoto K. (1989) Quantitation and immunohistochemical localization of cathepsins E and D in rat tissues and blood cells. Biochim. Biophys. Acta 991, 367375.
  • Santarelli L., Gobbi G., Blier P. and Hen R. (2002) Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK-1). J. Clin. Psychiatry 63, 1117.
  • Saria A. (1999) The tachykinin NK-1 receptor in the brain: pharmacology and putative functions. Eur. J. Pharmacol. 375, 5160.
  • Sastradipura D. F., Nakanishi H., Tsukuba T., Nishishita K., Sakai H., Kato Y., Gotow T., Uchiyama Y. and Yamamoto K. (1998) Identification of cellular compartments involved in processing of cathepsin E in primary cultures of rat microglia. J. Neurochem. 70, 20452056.
  • Sealy L., Mota F., Rayment N., Tatnell P., Kay J. and Chain B. (1996) Regulation of cathepsin E expression during human B cell differentiation in vitro. Eur. J. Immunol. 26, 18381843.
  • Shigematsu N., Yamamoto K., Higuchi S. and Fukuda T. (2006) Novel non-uniform distribution of serotonin transporter in the mouse hippocampus and neocortex revealed by N- and C-terminal domain-specific immunohistochemistry. Brain Res. 1075, 110116.
  • Sturiale S., Barbara G., Qiu B., Figini M., Geppetti P., Gerard N., Gerard C., Grady E. F., Bunnett N. W. and Collins S. M. (1999) Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA 96, 1165311658.
  • Tsukuba T., Okamoto K., Okamoto Y. et al. (2003) Association of cathepsin E deficiency with development of atopic dermatitis. J. Biochem. 134, 893902.
  • Tsukuba T., Yamamoto S., Yanagawa M., Okamoto K., Okamoto Y., Nakayama K. I., Kadowaki T. and Yamamoto K. (2006) Cathepsin E-deficient mice show increased susceptibility to bacterial infection associated with the decreased expression of multiple cell surface Toll-like receptors. J. Biochem. 140, 5766.
  • Varty G. B., Cohen-Williams M. E. and Hunter J. C. (2003) The antidepressant-like effects of neurokinin NK-1 receptor antagonists in a gerbil tail suspension test. Behav Pharmacol. 14, 8795.
  • Watling K. J. and Krause J. E. (1993) The rising sun shines on substance P and related peptides. Trends Pharmacol. Sci. 14, 8184.
  • Yamano M., Hillyard C. J., Girgis S., MacIntyre I., Emson P. C. and Tohyama M. (1988) Presence of a substance P-like immunoreactive neurone system from the parabrachial area to the central amygdaloid nucleus of the rat with reference to coexistence with calcitonin gene-related peptide. Brain Res. 451, 179188.
  • Yanagawa M., Tsukuba T., Okamoto K., Takii R., Terada Y., Kadowaki T. and Yamamoto K. (2006) Up-regulation, enhanced maturation, and secretion of cathepsin E in mouse macrophages treated with interferon-γ or lipopolysaccharide. J Oral Biosci. 48, 218225.
  • Yanagawa M., Tsukuba T., Nishioku T., Okamoto Y., Okamoto K., Takii R., Terada Y., Nakayama K. I., Kadowaki T. and Yamamoto K. (2007) Cathepsin E deficiency induces a novel form of lysosomal storage disorder showing the accumulation of lysosomal membrane sialoglycoproteins and the elevation of lysosomal pH in macrophages. J. Biol. Chem. 282, 18511862.